Alteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia
- PMID: 6156957
- PMCID: PMC371692
- DOI: 10.1172/JCI109895
Alteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia
Abstract
In vivo androgen kinetics were determined in six young (21--49 yr) and elderly men (62-77 yr) with prostatge hyperplasia (BPH). Steady-state infusions of [14C]testosterone and [3H]androstanediol (3 alpha diol) were given, which allowed determination of the conversions testosterone leads to dihydrotesterone (DHT) in equilibrium or formed from 3 alpha diol. These infusions also yield metabolic clearance data which, together with meaurement of nonisotopic steroid levels, yield estimations of blood production rates. The production rate for testosterone was 6.04 +/- 1.66 vs. 3.69 +/- 0.62 mg/d, whereas the production rate for 3 alpha diol was 319 +/- 57 and 193 +/- 34 micrograms/d (P < 0.05 both groups). The irreversible conversion rate of testosterone to DHT was 3.1 +/- 0.4 and 3.5 +/- 0.9% (NS). The back conversion of 3 alpha diol to dHT was high (68 +/- 25 vs. 81 +/- 17, NS) indicating that 3 alpha diol might cause BPH as a result of conversion to DHT in vivo. The conversion of DHT to 3 alpha diol is reduced in the elderly group (15.8 +/- 2.6 and 6.3 +/- 1.4, P < 0.001). Since DHT formation in the prostate is a key event in the development of BPH and blood DHT appears to be a measure of extrasplanchnic sexual target tissue activity, our in vivo studies suggest that the tissue increase in DHT may result from reduced metabolism and the activity of 3 alpha-oxidoreduction favors the oxidative pathway in elderly men.
Similar articles
-
Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.J Clin Endocrinol Metab. 1985 Feb;60(2):294-8. doi: 10.1210/jcem-60-2-294. J Clin Endocrinol Metab. 1985. PMID: 2578133
-
Dihydrotestosterone accumulation in genital skin fibroblasts derived from elderly men with prostatic hyperplasia.J Clin Endocrinol Metab. 1992 Aug;75(2):632-5. doi: 10.1210/jcem.75.2.1379259. J Clin Endocrinol Metab. 1992. PMID: 1379259
-
Studies on the origin of androstanediol and androstanediol glucuronide in young and elderly men.J Clin Endocrinol Metab. 1981 Apr;52(4):772-8. doi: 10.1210/jcem-52-4-772. J Clin Endocrinol Metab. 1981. PMID: 7204542
-
Dihydrotestosterone is a peripheral paracrine hormone.J Androl. 1992 Jan-Feb;13(1):23-7. J Androl. 1992. PMID: 1551803 Review.
-
Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.BJU Int. 2012 Jan;109(2):176-82. doi: 10.1111/j.1464-410X.2011.10651.x. Epub 2011 Oct 12. BJU Int. 2012. PMID: 21992222 Review.
Cited by
-
3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.J Clin Invest. 1982 May;69(5):1203-6. doi: 10.1172/jci110558. J Clin Invest. 1982. PMID: 7068855 Free PMC article.
-
An open label, dose response study to determine the effect of a dietary supplement on dihydrotestosterone, testosterone and estradiol levels in healthy males.J Int Soc Sports Nutr. 2008 Aug 12;5:12. doi: 10.1186/1550-2783-5-12. J Int Soc Sports Nutr. 2008. PMID: 18700016 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous